Alterity Therapeutics-ADRATHE
13F holders, Q1 2026 (March 31)15holders −3
0new positions
2sold out
1famous investor
$3.48avg. 13F price*
At the end of Q1 2026, 15 institutions reported holding Alterity Therapeutics-ADR (ATHE) in their 13F filings, down 3 from Q4 2025. 0 opened new positions and 2 sold out. The largest holders were Twin Lakes Capital Management, LLC ($485K), HB Wealth Management, LLC ($203K) and Morgan Stanley ($203K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Alterity Therapeutics-ADR
- CUSIP
- 02155X205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $34 |
All 13F filers, Q4 2025 → Q1 2026: 4,332 shares bought and 8,517 shares sold, net −4,185 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| Twin Lakes Capital Management, LLC | 0.22% | No change | 139,258 | $485K |
| HB Wealth Management, LLC | 0.00% | No change | 58,460 | $203K |
| Morgan Stanley | 0.00% | Reduce -8.3% | 58,382 | $203K |
| Greenleaf Trust | 0.00% | No change | 32,000 | $111K |
| Citadel Advisors | 0.00% | Add +19.4% | 20,077 | $71K |
| BNP Paribas Financial Markets | 0.00% | Reduce -1.4% | 6,809 | $24K |
| Rhumbline Advisers | 0.00% | Reduce -7.4% | 1,970 | $7K |
| GAMMA Investing LLC | 0.00% | Add +134.9% | 1,856 | $6K |
| Acadian Asset Management LLC | 0.00% | Reduce -61.2% | 1,863 | $6K |
| Osaic Holdings, Inc. | 0.00% | Reduce -16.1% | 68 | $240 |
| Blue Trust, Inc. | 0.00% | No change | 40 | $139 |
| Farther Finance Advisors, LLC | 0.00% | No change | 22 | $80 |
| CoreCap Advisors, LLC | 0.00% | No change | 21 | $73 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 6 | $21 |
| Danske Bank A/S | 0.00% | No change | 1 | $4 |
"% of holder's portfolio" is ATHE's weight in each manager's 13F, not the share of Alterity Therapeutics-ADR the manager owns.